Nuclear factor-κB activity and arterial response to balloon injury

Atherosclerosis

Volumn 131, Issue 1, 1997, Pages 59-66

  Cercek, Bojan ^a,b   Yamashita, Makoto ^a   Dimayuga, Paul ^a   Zhu, Jenny ^a   Fishbein, Michael C ^a   Kaul, Sanjay ^a   Shah, Prediman K ^a   Nilsson, Jan ^b   Regnstrom, Jan ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Aspirin; Balloon injury; Neointima; NF B; Smooth muscle

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTERY INJURY; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ARTERY; BALLOON DILATATION; CELL DIVISION; CELL NUCLEUS; INJURY; METABOLISM; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIES; ASPIRIN; BALLOON DILATATION; CELL DIVISION; CELL NUCLEUS; ENDOTHELIUM, VASCULAR; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; MALE; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030612687     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06767-6     Document Type: Article

References (32)

1. Grimm S, Baeuerle PA. The inducible transcription factor NF-κB: structure-function relationship of its protein subunits. Biochem J 1993;290:297.
2. Collins T. Endothelial nuclear factor-κB and the initiation of atherosclerotic lesion. Lab Invest 1993;68:499.
3. Bellas RE, Lee JS, Sonnenshein GE. Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine smooth muscle cells. J Clin Invest 1995;96:2521.
4. Hatada EN, Nieters A, Wulczyn FG, Naumann M, Meyer R, Nucifora G, McKeithan TW, Scheidereit C. The ankyrin repeat of the NF-κB precursor p 105 and the prooncogene bcl-3 act as specific inhibitors of NF-κB DNA binding. Proc Natl Acad Sci USA 1992;89:2489.
5. Henkel T, Zabel U, van Zee K, Muller JM, Fanning E, Baeuerle PA. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit. Cell 1992;68:1121.
6. Kopp E, Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994;265:956.
7. Weber C, Erl W, Pietsch A, Weber PC. Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 1995;91:1914.
8. Weber C, Erl W, Pietsch A, Strobel M, Zeigler-Heitbrock HWL, Weber PC. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule 1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb 1994;14:1665.
9. Ledebur HC, Parks TP. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. J Biol Chem 1995;270:933.
10. Yasukawa H, Imaizumi T, Matsuoka H, Nakashima A, Kohno K, Miyamoto T, Motimatsu M. Inhibition of intimal hyperplasia after balloon injury by antibodies to ICAM-1 (CD54) and LFA-1 (CD11a/CD18). Circulation 1995;92:1.
11. Kaltschmidt C, Kaltschmidt B, Henkel T, Stockinger H, Baeuerle PA. Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody. Biol Chem Hoppe-Seyler 1995;376:9.
12. Palinski W, Tangirala RK, Miller E, Young SG, Witztum JL. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vase Biol 1995;15:1569.
13. Lawrence R, Chang L-J, Siebenlist U, Bressler P, Sonenshein GE. Vascular smooth muscle cells express a constitutive NF-κB-like activity. J Biol Chem 1994;269:28913.
14. Li H, Cybuiski MI, Gimbrone MA, Libby P. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and in within rabbit atheroma. Am J Pathol 1993;143:1551.
15. Tanaka H, Sukhova GK, Swanson SJ, Clinton SK, Ganz P, Cybulski MI, Libby P. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 1993;88:1788.
16. Couffinhal T, Duplaa C, Labat L, Lamaziere J-M D, Moreau C, Printseva O, Bonnet J. Tumor necrosis factor-α stimulates ICAM-1 expression in human vascular smooth muscle cells. Arterioscler Thromb 1993;13:407.
17. Bernhardt J, Rogalla K, Luscher TF, Buhler FR, Resink TJ. Acetylsalicylic acid, at high concentrations, inhibits vascular smooth muscle cell proliferation J Cardiovasc Pharmacol 1993;21:973.
18. Schreck P, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991;10:2247.
19. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med 1992:175:1181.
20. Sagone AL, Husney RM. Oxidation of salicylates by stimulated granulocytes:evidence that these drugs act as free radical scavengers in biological systems. J Immunol 1987;138:2177.
21. Kazmi SMI, Plante RK, Visconti V, Taylor GR, Zhou L, Lau CY. Suppression of NF-κB activation and NF-κB dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase. J Cell Biochem 1995;57:299.
22. Naumann M, Scheidereit C. Activation of NF-κB in vivo is regulated by multiple phoshorylations. EMBO J 1994;13:4597.
23. Lenardo MJ, Baltimore D. NF-κB: a pleotropic mediator of inducible and tissue-specific gene control. Cell 1989;58:227.
24. Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T. Salicylates inhibit Iκ-a phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol 1996, 3961.
25. Autieri MV, Yue T-L, Ferstein GZ, Ohistein E. Antisense oligonucleotides to the p65 subunit of NF-κB inhibit human smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries. Biochem Biophys Res Commun 1995;213:827.
26. Duyao MP, Buckler AJ, Sonenshein GE. Interaction of an NF-κB-like factor with a site upstream of the c-myc promoter. Proc Natl Acad Sci USA 1990;87:4727.
27. Edelman ER, Simons M, Sirois MG, Rosenberg RD. c-myc in vasculoproliferative disease. Circ Res 1995;76:176.
28. La Rosa F, Pierce JW, Sonnenshein GE. Differential regulation of the c-myc oncogene promoter by the NF-κB rel family of transcription factors. Mol Cell Biol 1994;14:1039.
29. Libby P, Li H. Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. J Clin Invest 1993;92:538.
30. Faxon DP, Sanborn TA, Raudenschild CC, Ryan TJ. Effect of antiplatelet drugs on restenosis following experimental angioplasty. Am J Cardiol 1987;60:72C.
31. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR. Aspirin and dipyridamol in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988;318:1714.
32. Darius H, Sellig S, Belz GG, Darius BN. Aspirin 500 mg/d is superior to 100 and 40 mg/d for prevention of restenosis. Circulation 1994;90:1.